SciVision Biotech Inc
TWSE:1786

Watchlist Manager
SciVision Biotech Inc Logo
SciVision Biotech Inc
TWSE:1786
Watchlist
Price: 90.4 TWD -1.74% Market Closed
Market Cap: 6.4B TWD
Have any thoughts about
SciVision Biotech Inc?
Write Note

Intrinsic Value

The intrinsic value of one SciVision Biotech Inc stock under the Base Case scenario is 178.54 TWD. Compared to the current market price of 90.4 TWD, SciVision Biotech Inc is Undervalued by 49%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
178.54 TWD
Undervaluation 49%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
SciVision Biotech Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SciVision Biotech Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SciVision Biotech Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

SciVision Biotech Inc
TW
Health Care
Market Cap
6.4B TWD
IPO
Dec 29, 2010
Employees
-
Taiwan
Market Cap
6.4B TWD
Industry
Health Care
IPO
Dec 29, 2010

SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2010-12-29. The firm primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The firm is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The firm operates its business in the Americas, Europe, Asia, Middle East and Africa.

[ Read More ]

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about SciVision Biotech Inc

Provide an overview of the primary business activities
of SciVision Biotech Inc.

What unique competitive advantages
does SciVision Biotech Inc hold over its rivals?

What risks and challenges
does SciVision Biotech Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for SciVision Biotech Inc.

Provide P/S
for SciVision Biotech Inc.

Provide P/E
for SciVision Biotech Inc.

Provide P/OCF
for SciVision Biotech Inc.

Provide P/FCFE
for SciVision Biotech Inc.

Provide P/B
for SciVision Biotech Inc.

Provide EV/S
for SciVision Biotech Inc.

Provide EV/GP
for SciVision Biotech Inc.

Provide EV/EBITDA
for SciVision Biotech Inc.

Provide EV/EBIT
for SciVision Biotech Inc.

Provide EV/OCF
for SciVision Biotech Inc.

Provide EV/FCFF
for SciVision Biotech Inc.

Provide EV/IC
for SciVision Biotech Inc.

Show me price targets
for SciVision Biotech Inc made by professional analysts.

What are the Revenue projections
for SciVision Biotech Inc?

How accurate were the past Revenue estimates
for SciVision Biotech Inc?

What are the Net Income projections
for SciVision Biotech Inc?

How accurate were the past Net Income estimates
for SciVision Biotech Inc?

What are the EPS projections
for SciVision Biotech Inc?

How accurate were the past EPS estimates
for SciVision Biotech Inc?

What are the EBIT projections
for SciVision Biotech Inc?

How accurate were the past EBIT estimates
for SciVision Biotech Inc?

Compare the revenue forecasts
for SciVision Biotech Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of SciVision Biotech Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of SciVision Biotech Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of SciVision Biotech Inc compared to its peers.

Compare the P/E ratios
of SciVision Biotech Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing SciVision Biotech Inc with its peers.

Analyze the financial leverage
of SciVision Biotech Inc compared to its main competitors.

Show all profitability ratios
for SciVision Biotech Inc.

Provide ROE
for SciVision Biotech Inc.

Provide ROA
for SciVision Biotech Inc.

Provide ROIC
for SciVision Biotech Inc.

Provide ROCE
for SciVision Biotech Inc.

Provide Gross Margin
for SciVision Biotech Inc.

Provide Operating Margin
for SciVision Biotech Inc.

Provide Net Margin
for SciVision Biotech Inc.

Provide FCF Margin
for SciVision Biotech Inc.

Show all solvency ratios
for SciVision Biotech Inc.

Provide D/E Ratio
for SciVision Biotech Inc.

Provide D/A Ratio
for SciVision Biotech Inc.

Provide Interest Coverage Ratio
for SciVision Biotech Inc.

Provide Altman Z-Score Ratio
for SciVision Biotech Inc.

Provide Quick Ratio
for SciVision Biotech Inc.

Provide Current Ratio
for SciVision Biotech Inc.

Provide Cash Ratio
for SciVision Biotech Inc.

What is the historical Revenue growth
over the last 5 years for SciVision Biotech Inc?

What is the historical Net Income growth
over the last 5 years for SciVision Biotech Inc?

What is the current Free Cash Flow
of SciVision Biotech Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for SciVision Biotech Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
SciVision Biotech Inc

Current Assets 1B
Cash & Short-Term Investments 782.4m
Receivables 129.6m
Other Current Assets 105.1m
Non-Current Assets 1.1B
Long-Term Investments 50k
PP&E 1.1B
Intangibles 1.8m
Other Non-Current Assets 8.9m
Current Liabilities 123.4m
Accounts Payable 14.1m
Other Current Liabilities 109.3m
Non-Current Liabilities 198.2m
Long-Term Debt 159m
Other Non-Current Liabilities 39.2m
Efficiency

Earnings Waterfall
SciVision Biotech Inc

Revenue
831.4m TWD
Cost of Revenue
-209.7m TWD
Gross Profit
621.7m TWD
Operating Expenses
-372.6m TWD
Operating Income
249.1m TWD
Other Expenses
-33.1m TWD
Net Income
216m TWD

Free Cash Flow Analysis
SciVision Biotech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

SciVision Biotech Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
Positive Operating Income
Positive 3-Years Revenue Growth
65/100
Profitability
Score

SciVision Biotech Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

SciVision Biotech Inc's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

SciVision Biotech Inc's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
SciVision Biotech Inc

There are no price targets for SciVision Biotech Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SciVision Biotech Inc?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SciVision Biotech Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one SciVision Biotech Inc stock?

The intrinsic value of one SciVision Biotech Inc stock under the Base Case scenario is 178.54 TWD.

Is SciVision Biotech Inc stock undervalued or overvalued?

Compared to the current market price of 90.4 TWD, SciVision Biotech Inc is Undervalued by 49%.

Back to Top